<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001992219</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001662579</issuerCik>
<issuerName>C4 Therapeutics, Inc.</issuerName>
<secFileNumber>001-39567</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">490 Arsenal Way Suite 120</street1>
<city xmlns="http://www.sec.gov/edgar/common">Watertown</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">2472</zipCode>
</issuerAddress>
<issuerContactPhone>617-231-0700</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Mark Mossler</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Former Section 16 Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Stock Options</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>E*Trade</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3 Edison Drive</street1>
<city xmlns="http://www.sec.gov/edgar/common">Alpharetta</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">GA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">30005</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>9087</noOfUnitsSold>
<aggregateMarketValue>35484.74</aggregateMarketValue>
<noOfUnitsOutstanding>110567222</noOfUnitsOutstanding>
<approxSaleDate>05/27/2026</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Stock Options</securitiesClassTitle>
<acquiredDate>02/14/2025</acquiredDate>
<natureOfAcquisitionTransaction>Grant under Issuer's 2020 Equity Incentive Plan</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>C4 Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>29080</amountOfSecuritiesAcquired>
<paymentDate>02/14/2025</paymentDate>
<natureOfPayment>These securities were acquired pursuant to an option grant under the Issuer's 2020 Equity Incentive Plan. 29,080 options were granted on February 14, 2025, of which 9,087 vested and were exercised and sold pursuant to a same-day sale transaction.</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<noticeSignature>
<noticeDate>05/28/2026</noticeDate>
<signature>Mark Mossler</signature>
</noticeSignature>
</formData>
</edgarSubmission>
